Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes

NCT02312063 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Sitagliptin
DRUG: Glimepiride

Sponsor

Kansai Electric Power Hospital

Collaborators

[object Object]